Baldwin Insurance saw its IBD SmartSelect Composite Rating jump to 97 Wednesday, up from 93 the day before. The upgraded Composite score show that Baldwin stock ranks among the top 3% of all stocks in IBD's database.
The Composite score combines five separate proprietary ratings into one. The best growth stocks have a Composite Rating of 90 or better. Baldwin is putting up outstanding fundamentals numbers and it isn't alone in the insurance group. As a whole, insurers are outperforming the market.
Baldwin Gained 53% In 10-1/2 Months
Baldwin stock closed at 26.08 on April 30, 2024. From there it shot up more than 100% to a 55.82 on Oct. 17. It consolidated from there. Notably, its stock has moved sideways so far this year, shrugging off the gloom-and-doom hovering over the market in recent weeks. Wednesday Baldwin closed at 39.95, down for the day but up 53% in less than 11 months.
Lean How — And When — To Sell Stocks
Baldwin stock also sports a 97 EPS Rating, which means its recent quarterly and longer-term annual earnings growth is outpacing 97% of all stocks. Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
Profits Surged 94% Last Quarter
In Q4, the company posted 93% EPS growth, to 27 cents per share. Top line growth increased 16% to $329.9 million. It's reported double-digit profit and sales growth every quarter this past year.
Baldwin Insurance holds the No. 5 rank among its peers in the Insurance-Brokers industry group. Ryan Specialty is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
Please follow James DeTar on Twitter @JimDeTar
